Amphastar Pharmaceuticals, Inc. (AMPH)
22.86
+0.33
(+1.46%)
USD |
NASDAQ |
Sep 01, 10:11
Amphastar Pharmaceuticals Cash from Operations (TTM) : 184.61M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 184.61M |
| March 31, 2026 | 168.88M |
| December 31, 2025 | 156.12M |
| September 30, 2025 | 152.28M |
| June 30, 2025 | 159.66M |
| March 31, 2025 | 193.17M |
| December 31, 2024 | 213.39M |
| September 30, 2024 | 208.23M |
| June 30, 2024 | 212.60M |
| March 31, 2024 | 198.41M |
| December 31, 2023 | 183.50M |
| September 30, 2023 | 174.86M |
| June 30, 2023 | 130.59M |
| March 31, 2023 | 78.39M |
| December 31, 2022 | 88.77M |
| September 30, 2022 | 113.99M |
| June 30, 2022 | 96.50M |
| March 31, 2022 | 125.93M |
| December 31, 2021 | 97.99M |
| September 30, 2021 | 74.45M |
| June 30, 2021 | 80.68M |
| March 31, 2021 | 78.61M |
| December 31, 2020 | 57.27M |
| September 30, 2020 | 46.02M |
| Date | Value |
|---|---|
| June 30, 2020 | 25.22M |
| March 31, 2020 | 46.85M |
| December 31, 2019 | 41.76M |
| September 30, 2019 | 45.63M |
| June 30, 2019 | 73.41M |
| March 31, 2019 | 26.22M |
| December 31, 2018 | 38.19M |
| September 30, 2018 | 38.44M |
| June 30, 2018 | 25.13M |
| March 31, 2018 | 25.17M |
| December 31, 2017 | 39.21M |
| September 30, 2017 | 43.45M |
| June 30, 2017 | 42.28M |
| March 31, 2017 | 47.03M |
| December 31, 2016 | 38.56M |
| September 30, 2016 | 27.84M |
| June 30, 2016 | 30.10M |
| March 31, 2016 | 23.27M |
| December 31, 2015 | 10.68M |
| September 30, 2015 | 19.72M |
| June 30, 2015 | 29.79M |
| March 31, 2015 | 28.22M |
| December 31, 2014 | 21.05M |
| September 30, 2014 | 17.24M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Viatris, Inc. | 2.331B |
| Supernus Pharmaceuticals, Inc. | 19.91M |
| Liquidia Corp. | 167.71M |
| ANI Pharmaceuticals, Inc. | 189.47M |
| Corcept Therapeutics, Inc. | 109.70M |